19 related articles for article (PubMed ID: 6231030)
1. Structural insight into function and regulation of carnitine palmitoyltransferase.
Rufer AC; Thoma R; Hennig M
Cell Mol Life Sci; 2009 Aug; 66(15):2489-501. PubMed ID: 19430727
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone.
Foxworthy PS; Eacho PI
Biochem J; 1988 Jun; 252(2):409-14. PubMed ID: 3415664
[TBL] [Abstract][Full Text] [Related]
3. The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations.
Turnbull DM; Bartlett K; Younan SI; Sherratt HS
Biochem Pharmacol; 1984 Feb; 33(3):475-81. PubMed ID: 6704164
[TBL] [Abstract][Full Text] [Related]
4. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells.
Vaartjes WJ; De Haas CG; Haagsman HP
Biochem Pharmacol; 1986 Dec; 35(23):4267-72. PubMed ID: 3790153
[TBL] [Abstract][Full Text] [Related]
6. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on carbohydrate and fatty acid metabolism in liver and muscle.
Schudt C; Simon A
Biochem Pharmacol; 1984 Nov; 33(21):3357-62. PubMed ID: 6437406
[TBL] [Abstract][Full Text] [Related]
7. Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2-carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes.
Agius L; Pillay D; Alberti KG; Sherratt HS
Biochem Pharmacol; 1985 Aug; 34(15):2651-4. PubMed ID: 2861821
[TBL] [Abstract][Full Text] [Related]
8. Metabolic changes in fed rats caused by chronic administration of ethyl 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate, a new hypoglycaemic compound.
Koundakjian PP; Turnbull DM; Bone AJ; Rogers MP; Younan SI; Sherratt HS
Biochem Pharmacol; 1984 Feb; 33(3):465-73. PubMed ID: 6231030
[TBL] [Abstract][Full Text] [Related]
9. Influence of etomoxir on the expression of several genes in liver, testis and heart.
Hegardt FG; Serra D; Asins G
Gen Pharmacol; 1995 Sep; 26(5):897-904. PubMed ID: 7557264
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
